Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:6645
TSE:6645Electronic

Why OMRON (TSE:6645) Is Up 15.7% After Profit Surges On Modest Sales Growth And What's Next

OMRON Corporation has reported past earnings for the nine months ended December 31, 2025, with sales rising to ¥614,288 million from ¥579,698 million and net income increasing to ¥14,338 million from ¥7,183 million a year earlier, while basic earnings per share from continuing operations grew to ¥72.87 from ¥36.47. The sharp improvement in net income outpacing the rise in sales suggests a meaningful uplift in profitability, potentially reflecting better cost control or a more profitable...
NasdaqGS:PAGP
NasdaqGS:PAGPOil and Gas

Assessing Plains GP Holdings (PAGP) Valuation After Recent Share Price Swings

Plains GP Holdings overview Plains GP Holdings (PAGP) has recently shown mixed short term moves, with a 2.3% decline over the past day contrasting with gains over the past week, month, and past 3 months, putting recent trading in sharper focus for investors. See our latest analysis for Plains GP Holdings. That 2.3% one day drop sits against a 7.9% 30 day share price return and an 18.2% 90 day share price return, while the 5 year total shareholder return of 249.2% highlights how powerful...
NYSE:INSP
NYSE:INSPMedical Equipment

A Look At Inspire Medical Systems (INSP) Valuation After Recent Share Price Weakness

Why Inspire Medical Systems is on investors’ radar Inspire Medical Systems (INSP) has been drawing attention after a stretch of weak share performance, including a one-month return of about 34% and a past three-month decline near 20%. For a company focused on minimally invasive treatments for obstructive sleep apnea, that kind of pullback naturally raises questions about how current pricing relates to its fundamentals, including recent revenue of US$882.622 million and net income of US$44.556...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Assessing PTC (PTC) Valuation After Earnings Beat And Raised AI Driven Guidance

What triggered the latest move in PTC (PTC)? PTC (PTC) is back in focus after reporting quarterly results that exceeded market expectations, raising revenue and earnings guidance, and highlighting progress in embedding AI tools like Windchill AI Parts Rationalization across its software portfolio. See our latest analysis for PTC. Despite the earnings beat, guidance raise, and ongoing buybacks, momentum in PTC’s share price has been soft, with a 30 day share price return of 10.8% and a 1 year...
TSX:CM
TSX:CMBanks

A Look At Canadian Imperial Bank of Commerce’s Valuation As Fresh Bond Issuances Reshape Its Funding Profile

Why CIBC’s fresh bond activity matters for stock investors Canadian Imperial Bank of Commerce (TSX:CM) has been busy in the bond market, issuing a series of senior secured and unsecured notes with fixed and variable coupons across maturities stretching into the 2030s and 2040s. For you as a shareholder or potential buyer, this cluster of offerings is important because it shapes how the bank funds itself, manages regulatory capital needs, and balances costs between equity and debt over...
BIT:BMED
BIT:BMEDDiversified Financial

Assessing Banca Mediolanum (BIT:BMED) Valuation After Strong Earnings Dividend And AI Initiatives

Why Banca Mediolanum (BIT:BMED) is back in focus after fresh earnings Banca Mediolanum (BIT:BMED) is on investors’ radar after reporting fourth quarter and full year 2025 results, with net income of €511.9 million for the quarter and €1.238 billion for the year. See our latest analysis for Banca Mediolanum. The strong fourth quarter and full year results, together with the proposed dividend and focus on AI driven efficiency and high net worth clients, come after a 9.65% 90 day share price...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Does JD.com’s Dim Sum Bond Plan Reshape Its Logistics‑Led Ecosystem Strategy (JD)?

In recent days, JD.com has reportedly explored issuing up to ¥10 billion in offshore yuan “dim sum” bonds with maturities up to 10 years, while pushing ahead with global logistics investments such as its new Riyadh hub and the expansion of its JD MALL concept in China. These funding and ecosystem moves, including deeper membership-based loyalty integration across its platform, highlight how JD.com is using balance-sheet flexibility to reinforce its role as a full-service commerce and...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Is Workday’s (WDAY) Veteran Skills Mapper a Niche Feature or a Strategic Talent-Data Play?

In early February 2026, Workday launched Military Skills Mapper, a new Workday Recruiting feature that translates veterans’ military experience into civilian-equivalent skills to help employers more effectively identify and hire former service members. This tool directly targets a frequently overlooked talent pool by converting complex military roles into clearer, business-aligned language that hiring teams can easily act on. We’ll now examine how this focus on veteran skills translation...
NYSE:EPR
NYSE:EPRSpecialized REITs

A Look At EPR Properties (EPR) Valuation After New Equity Offering And Expanded Investment Plans

EPR Properties (EPR) has drawn fresh attention after launching a $400 million at the market equity offering and lifting its 2025 investment spending expectations following recent golf course and water park acquisitions. See our latest analysis for EPR Properties. Those new acquisitions and the $400 million equity program have arrived against a backdrop of firm share price momentum, with a 30 day share price return of 9.05% and a year to date share price return of 10.82%. The 1 year total...
ENXTLS:BCP
ENXTLS:BCPBanks

A Look At Banco Comercial Português (ENXTLS:BCP) Valuation After Its €499.95 Million Bond Issuance

Bond issuance sets the scene for Banco Comercial Português stock Banco Comercial Português (ENXTLS:BCP) has just raised about €499.95 million through Fixed to Floating Rate Senior Preferred Notes due 2032, a move that reshapes its funding mix and liquidity profile. This new callable, senior, variable rate bond, issued at 99.99% of its €500 million principal, gives investors another way to assess the bank’s balance sheet strength alongside its shares. See our latest analysis for Banco...
SWX:SIGN
SWX:SIGNPackaging

Assessing SIG Group (SWX:SIGN) Valuation After Planned CEO Transition And Leadership Reset

CEO transition puts SIG Group in focus SIG Group (SWX:SIGN) has confirmed that Mikko Keto will become CEO on 1 March 2026, while interim CEO Anne Erkens will return to her CFO role. This planned transition is being closely watched by shareholders. See our latest analysis for SIG Group. At a share price of CHF12.0, SIG Group has seen a 44.84% 90 day share price return. However, its 1 year total shareholder return of 36.91% indicates that longer term momentum has been weak and sentiment is...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

How ACI’s Alpha Cash Underbanked Payments Deal Could Shape ACI Worldwide’s (ACIW) Investor Story

In early February 2026, Alpha Modus Financial Services announced a multi-year agreement for ACI Worldwide to provide hosted remittance and bill payment services across the Alpha Cash retail ecosystem, supporting both digital and paper-based transactions nationwide. This deal highlights ACI’s role in powering financial access for underbanked consumers by embedding enterprise-grade payments infrastructure directly into everyday retail locations. We’ll now examine how powering Alpha Cash’s...
OM:BOL
OM:BOLMetals and Mining

Is It Too Late To Consider Boliden (OM:BOL) After A 65% One Year Surge?

If you are wondering whether Boliden shares still offer value after a strong run, this article will help you size up the price you are paying versus what you are getting. Boliden's share price recently closed at SEK 624.8, with returns of 14.2% over 30 days and 65.0% over 1 year, which may change how investors think about both upside and risk. Recent coverage around Boliden has focused on its role in materials and mining, with investors watching how commodity demand and supply conditions...
TSE:7203
TSE:7203Auto

Toyota CEO Shift To Kenta Kon Puts Profitability And Tariffs In Focus

Toyota Motor (TSE:7203) has appointed current CFO Kenta Kon as its new CEO. Kon will succeed Koji Sato, marking Toyota's second CEO change in three years. Sato will move into a new role focused on wider industry collaboration and partnerships. The leadership reshuffle is intended to speed up decision-making as the auto sector faces rapid change in mobility and global economic conditions. Toyota, one of the world's largest automakers by volume, sits at the center of major shifts in how...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Has Alignment Healthcare (ALHC) Run Ahead Of Its Value After Recent Share Price Strength?

If you are wondering whether Alignment Healthcare's share price still reflects its true worth after recent moves, you are not alone. The stock closed at US$21.75, with a 7 day return of a 3.5% decline, a 30 day return of 3.9%, a year to date return of 7.6%, and a 1 year return of 47.6%. This provides context for anyone weighing up the current risk and reward trade off. Recent news coverage has focused on Alignment Healthcare's position in the US healthcare market and how investors are...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

A Look At Enphase Energy (ENPH) Valuation After Earnings Beat And Upbeat Guidance

Enphase Energy (ENPH) is back in focus after its latest earnings report topped market expectations on both revenue and earnings, paired with first quarter guidance that came in above analyst forecasts. See our latest analysis for Enphase Energy. The latest update has triggered a sharp rebound in sentiment, with a 1 day share price return of 5.35% and a 90 day share price return of 64.79%. However, the 1 year total shareholder return remains a 21.61% loss, so recent momentum is rebuilding from...
NYSE:WBS
NYSE:WBSBanks

Is Webster Financial (WBS) Pricing Reflect Its Recent 1-Year 23.7% Share Price Gain

If you are wondering whether Webster Financial's recent share price puts it in the bargain bin or the overpay zone, this article will help you frame that question clearly before you make any moves. The stock last closed at US$73.13, with returns of 11.2% over 7 days, 13.2% over 30 days, 14.6% year to date, 23.7% over 1 year, 46.9% over 3 years and 71.0% over 5 years. These figures provide useful context before you look at what the business might be worth. Recent attention on Webster...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

AppFolio (APPF) Valuation Check After Shelf Registration Earnings Update And New Revenue Guidance

Why AppFolio is back on investors’ radar AppFolio (APPF) has drawn fresh attention after filing an approximately US$80.8 million shelf registration tied to an ESOP related Class A share offering, following recent earnings and 2026 revenue guidance. See our latest analysis for AppFolio. After AppFolio set 2026 revenue guidance and reported full year numbers, the 30 day share price return of 20.42% decline and year to date share price return of 21.98% decline suggest momentum has cooled, even...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Why Align Technology (ALGN) Is Up 15.1% After Record 2025 Aligner Volumes And Measured 2026 Outlook

In early February 2026, Align Technology reported fourth-quarter 2025 revenue of US$1,047.56 million and net income of US$135.76 million, capping a full year of just over US$4.03 billion in sales and slightly higher earnings per share than 2024. Alongside these results, Align guided to modest 2026 revenue growth and highlighted record clear aligner volumes, expanding dental service organization partnerships, and continued investment in digital orthodontic technology, including its iTero...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After Recent Share Price Momentum

Setting the scene for BioMarin Pharmaceutical BioMarin Pharmaceutical (BMRN) has been drawing attention after recent share price swings, with a 1 day return of 1.7% and a past 3 months return of 13.0% catching investor eyes. See our latest analysis for BioMarin Pharmaceutical. At a share price of $58.13, BioMarin Pharmaceutical’s recent 90 day share price return of 13.0% contrasts with a 1 year total shareholder return decline of 9.1%. This suggests shorter term momentum alongside weaker...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Margin Decline Challenges Bullish Earnings Growth Narratives

Fortinet (FTNT) has wrapped up FY 2025 with fourth quarter revenue of about US$1.9b and basic EPS of US$0.68, alongside net income excluding extra items of US$506m. This gives investors a clear read on its recent trading momentum. The company has seen quarterly revenue move from US$1.66b in Q4 2024 to US$1.91b in Q4 2025, while basic EPS shifted from US$0.69 to US$0.68 over the same period. This sets the scene for a year where margins and profit quality remain in sharp focus. See our full...
TSE:7947
TSE:7947Packaging

Assessing FP Corporation (TSE:7947) Valuation After Strong Nine Month Earnings Update

FP Corporation (TSE:7947) has released earnings for the nine months ended December 31, 2025, giving investors fresh insight into how its packaging business is performing and how profits are tracking this fiscal year. See our latest analysis for FP. The recent earnings update arrives after a period where momentum in FP’s 1 day, 7 day and 90 day share price returns has been positive, even as its 1 year and multi year total shareholder returns remain negative. That mix suggests investors are...
SWX:UBSG
SWX:UBSGCapital Markets

Assessing UBS Group (SWX:UBSG) Valuation After Q4 2025 Results And Credit Suisse Integration Progress

UBS Group (SWX:UBSG) is back in focus after its Q4 2025 report showed net income of US$1.2b and full year profit of US$7.8b, along with progress on the Credit Suisse integration. See our latest analysis for UBS Group. The latest Q4 results, higher proposed dividend and the new share repurchase plan have arrived after a mixed run in the share price, with a 30 day share price return of 9.4% decline but a 90 day share price return of 11.53% and a 1 year total shareholder return of 14.88%,...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Neogen Recall Puts Veterinary Quality Controls And Investor Confidence In Focus

Neogen Corporation initiated a voluntary recall of its HYCOAT Hyaluronate Sodium Sterile Solution used in veterinary settings. The recall was triggered by microbial contamination identified in certain product lots. The affected product is intended for animal use, and the company has reported adverse events in animals linked to the issue. Neogen is working with the U.S. Food and Drug Administration on the recall process. For investors tracking Neogen (NasdaqGS:NEOG), this recall comes at a...